Magnesium Sulfate 50% Inj, 10ml

Manufacturer HOSPIRA Active Ingredient Magnesium Sulfate Injection(mag NEE zhum SUL fate) Pronunciation mag-NEE-zhum SUL-fate
It is used to treat or prevent low magnesium levels.It is used to prevent and control seizures during pregnancy.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Anticonvulsant; Electrolyte Supplement; Tocolytic
đŸ§Ŧ
Pharmacologic Class
Mineral; Electrolyte
🤰
Pregnancy Category
Category D
✅
FDA Approved
Jan 1970
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Magnesium sulfate is a mineral given by injection to treat certain medical conditions. It can help prevent seizures in pregnant women with severe pre-eclampsia or eclampsia, treat low magnesium levels in the body, or help with severe asthma attacks. It works by relaxing muscles and calming the nervous system.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to follow the dosage instructions carefully. This medication can be administered in two ways: as an injection into a muscle or as an infusion into a vein over a specified period.

Storing and Disposing of Your Medication

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the best storage method.

Missing a Dose

If you miss a dose, contact your doctor to receive guidance on what to do next.
💡

Lifestyle & Tips

  • Report any unusual symptoms immediately to your healthcare provider.
  • Do not take other medications or supplements without consulting your doctor, especially antacids or laxatives containing magnesium.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Eclampsia/Pre-eclampsia: Loading dose 4-6 g IV over 15-30 minutes, followed by maintenance infusion 1-2 g/hour IV. Hypomagnesemia (severe): 8-12 g IV over 5-6 hours, then 3-4 g/day IV/IM.
Dose Range: 1 - 12 mg

Condition-Specific Dosing:

Eclampsia/Pre-eclampsia: Loading dose 4-6 g IV over 15-30 minutes, followed by maintenance infusion 1-2 g/hour IV. Max 30-40 g/24 hours.
Hypomagnesemia (severe): 8-12 g IV over 5-6 hours, then 3-4 g/day IV/IM.
Torsades de Pointes: 1-2 g IV over 5-20 minutes, may repeat once.
Acute Asthma (severe): 2 g IV over 20 minutes.
đŸ‘ļ

Pediatric Dosing

Neonatal: Hypomagnesemia: 25-50 mg/kg/dose IV/IM every 8-12 hours for 3-4 doses. Max 2000 mg/24 hours.
Infant: Hypomagnesemia: 25-50 mg/kg/dose IV/IM every 8-12 hours for 3-4 doses. Max 2000 mg/24 hours.
Child: Hypomagnesemia: 25-50 mg/kg/dose IV/IM every 8-12 hours for 3-4 doses. Max 2000 mg/24 hours. Acute Asthma (severe): 25-50 mg/kg IV over 10-20 minutes (max 2 g).
Adolescent: Hypomagnesemia: 25-50 mg/kg/dose IV/IM every 8-12 hours for 3-4 doses. Max 2000 mg/24 hours. Acute Asthma (severe): 25-50 mg/kg IV over 10-20 minutes (max 2 g).
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Monitor closely; consider lower end of dosing range.
Moderate: Reduce dose by 25-50%; monitor serum magnesium and renal function closely. Avoid if possible in pre-eclampsia/eclampsia.
Severe: Contraindicated in severe renal impairment (CrCl < 30 mL/min) for pre-eclampsia/eclampsia. For other indications, significant dose reduction (e.g., 50-75%) and frequent monitoring are required. Avoid if possible.
Dialysis: Magnesium is dialyzable. Avoid use or use with extreme caution and frequent monitoring. Dosing post-dialysis may be required based on serum levels.

Hepatic Impairment:

Mild: No specific adjustment needed.
Moderate: No specific adjustment needed.
Severe: No specific adjustment needed.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Magnesium is an essential cofactor for many enzyme systems, including those involved in ATP production, nucleic acid synthesis, and muscle contraction. As an anticonvulsant, it depresses the central nervous system by blocking neuromuscular transmission and decreasing the amount of acetylcholine released at the motor end plate. It also acts as a physiological calcium antagonist, relaxing smooth muscle (e.g., uterine, bronchial, vascular) and reducing peripheral vascular resistance, leading to vasodilation and blood pressure reduction. It also has a direct myocardial depressant effect.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV)
Tmax: Immediate (IV)
FoodEffect: Not applicable (IV)

Distribution:

Vd: 0.2-0.3 L/kg (distributes into extracellular fluid and bone)
ProteinBinding: Approximately 30% (to albumin)
CnssPenetration: Limited (crosses blood-brain barrier slowly, but can achieve therapeutic levels in CSF)

Elimination:

HalfLife: Approximately 4 hours (normal renal function); significantly prolonged in renal impairment.
Clearance: Primarily renal clearance, proportional to glomerular filtration rate.
ExcretionRoute: Renal (urine)
Unchanged: 100%
âąī¸

Pharmacodynamics

OnsetOfAction: Immediate (IV)
PeakEffect: Minutes (IV)
DurationOfAction: Approximately 30 minutes (IV); 3-4 hours (IM)

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high magnesium levels, including:
+ Confusion
+ Feeling sluggish
+ Slow movements
+ Shortness of breath
+ Upset stomach
+ Severe dizziness or passing out
Signs of low calcium levels, such as:
+ Muscle cramps or spasms
+ Numbness and tingling
+ Seizures
Other severe side effects, including:
+ Slow heartbeat
+ Flushing
+ Inability to move
+ Changes in eyesight
+ Feeling cold
+ Excessive sweating

If you experience any of the following symptoms, seek medical help immediately, as they could be signs of a life-threatening muscle problem:
New or worsening muscle weakness
Trouble chewing or swallowing
Trouble breathing
Droopy eyelids
* Changes in eyesight, such as blurred vision or double vision

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you notice any side effects that bother you or do not go away.

Not all possible side effects are listed here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Feeling very tired or drowsy
  • Muscle weakness
  • Difficulty breathing or slow breathing
  • Feeling dizzy or lightheaded
  • Flushing or sweating
  • Slow heartbeat
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have a heart block or any pre-existing heart problems.
* If you are currently taking nifedipine or terbutaline, as these medications may interact with this drug.

Please note that this is not an exhaustive list of all potential interactions. To ensure your safety, it is crucial to disclose all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you may have. Your doctor and pharmacist need this information to determine whether it is safe for you to take this medication in conjunction with your other treatments.

Remember, do not start, stop, or adjust the dosage of any medication without first consulting your doctor to confirm that it is safe to do so.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. If you are following a low-magnesium diet, consult with your doctor to discuss any potential interactions.

Regular blood tests are crucial while taking this medication, as directed by your doctor. It is also important to discuss your test results with your doctor.

This medication may contain aluminum, which can lead to aluminum toxicity with long-term use. The risk of aluminum toxicity is higher in individuals with kidney problems and premature infants. Therefore, it is crucial to discuss this risk with your doctor.

If you have myasthenia gravis, do not take this medication, as it can cause severe and potentially life-threatening breathing problems.

Women who are pregnant or become pregnant while taking this medication should contact their doctor immediately, as it may harm the unborn baby.

If you are breast-feeding, inform your doctor, as you will need to discuss the potential risks to your baby and determine the best course of action.
🆘

Overdose Information

Overdose Symptoms:

  • Extreme drowsiness
  • Loss of reflexes (e.g., knee jerk)
  • Severe muscle weakness
  • Very slow or shallow breathing
  • Low blood pressure
  • Slow heart rate
  • Coma
  • Cardiac arrest

What to Do:

Immediate medical attention is required. The antidote is intravenous calcium gluconate. Call 911 or Poison Control (1-800-222-1222) immediately.

Drug Interactions

🔴

Major Interactions

  • Neuromuscular blocking agents (e.g., rocuronium, vecuronium): Potentiates and prolongs neuromuscular blockade, leading to increased risk of respiratory depression/paralysis.
  • Calcium channel blockers (e.g., nifedipine, amlodipine): Increased risk of hypotension and bradycardia due to additive vasodilatory and myocardial depressant effects.
  • CNS depressants (e.g., opioids, benzodiazepines, barbiturates, general anesthetics): Additive CNS depression, leading to increased sedation and respiratory depression.
🟡

Moderate Interactions

  • Digoxin: Magnesium sulfate can increase the risk of digoxin toxicity in patients with hypokalemia or hypomagnesemia, or if given rapidly IV.
  • Diuretics (loop and thiazide): May increase renal excretion of magnesium, potentially leading to hypomagnesemia (though magnesium sulfate is given to treat hypomagnesemia, this interaction is relevant for chronic use of diuretics).
  • Aminoglycosides: May potentiate neuromuscular blockade.
đŸŸĸ

Minor Interactions

  • Tetracyclines/Quinolones (oral): Magnesium can chelate these antibiotics, reducing their absorption (not relevant for IV magnesium sulfate).

Monitoring

đŸ”Ŧ

Baseline Monitoring

Serum Magnesium levels

Rationale: To establish baseline and guide initial dosing, especially in hypomagnesemia.

Timing: Prior to initiation of therapy.

Renal function (BUN, Creatinine, CrCl)

Rationale: Magnesium is renally excreted; impaired renal function increases risk of toxicity.

Timing: Prior to initiation of therapy.

Deep Tendon Reflexes (DTRs)

Rationale: Baseline assessment for comparison, as loss of DTRs is an early sign of hypermagnesemia.

Timing: Prior to initiation of therapy.

Vital Signs (BP, HR, RR)

Rationale: Baseline assessment for comparison, as hypotension and respiratory depression are signs of toxicity.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Serum Magnesium levels

Frequency: Every 4-6 hours during continuous infusion, or as clinically indicated.

Target: 4-7 mg/dL (for pre-eclampsia/eclampsia); 1.5-2.5 mg/dL (for hypomagnesemia correction)

Action Threshold: >7 mg/dL (loss of DTRs), >10 mg/dL (respiratory depression), >12 mg/dL (cardiac arrest); hold dose and consider calcium gluconate.

Deep Tendon Reflexes (DTRs)

Frequency: Hourly during continuous infusion.

Target: Present (2+)

Action Threshold: Absent DTRs (0); hold dose and assess for other signs of toxicity.

Respiratory Rate (RR)

Frequency: Hourly during continuous infusion.

Target: >12 breaths/min

Action Threshold: <12 breaths/min; hold dose and assess for other signs of toxicity, consider respiratory support.

Urine Output

Frequency: Hourly during continuous infusion.

Target: >25-30 mL/hour or >100 mL/4 hours

Action Threshold: <25 mL/hour; indicates impaired renal excretion and increased risk of toxicity.

Blood Pressure (BP)

Frequency: Hourly during continuous infusion.

Target: Individualized based on indication

Action Threshold: Significant hypotension; hold dose and assess.

đŸ‘ī¸

Symptom Monitoring

  • Lethargy
  • Drowsiness
  • Muscle weakness
  • Flushing
  • Sweating
  • Hypotension
  • Bradycardia
  • Absent deep tendon reflexes
  • Respiratory depression
  • Cardiac arrest

Special Patient Groups

🤰

Pregnancy

Category D. While associated with fetal abnormalities (e.g., hypocalcemia, skeletal abnormalities) with prolonged use (more than 5-7 days) during pregnancy, it is considered the drug of choice for the prevention and treatment of seizures in severe pre-eclampsia and eclampsia due to its life-saving benefits for the mother. Short-term use for these indications is generally considered safe and effective.

Trimester-Specific Risks:

First Trimester: Limited data, generally not used for prolonged periods in first trimester.
Second Trimester: Used for pre-eclampsia/eclampsia if indicated.
Third Trimester: Used for pre-eclampsia/eclampsia; prolonged exposure (more than 5-7 days) can lead to fetal bone demineralization, hypocalcemia, and respiratory depression in the neonate. Monitor neonate for signs of hypermagnesemia.
🤱

Lactation

Magnesium is a natural component of breast milk. While magnesium sulfate is excreted into breast milk, the amount is generally considered low and unlikely to cause adverse effects in a healthy, full-term infant. Monitor infant for signs of diarrhea or sedation. L3 (Moderately safe).

Infant Risk: Low risk for healthy, full-term infants. Monitor for loose stools or sedation.
đŸ‘ļ

Pediatric Use

Used for hypomagnesemia, severe acute asthma, and certain cardiac arrhythmias (e.g., Torsades de Pointes). Dosing is weight-based and requires careful monitoring of serum magnesium levels, vital signs, and DTRs due to risk of toxicity.

👴

Geriatric Use

Elderly patients are more likely to have impaired renal function, which increases the risk of magnesium toxicity. Lower doses and more frequent monitoring of serum magnesium, renal function, and clinical signs of toxicity are recommended.

Clinical Information

💎

Clinical Pearls

  • Always have calcium gluconate (10% solution, 10 mL IV over 3 minutes) readily available as an antidote for magnesium toxicity.
  • Administer IV magnesium sulfate slowly to avoid hypotension, flushing, and cardiac arrest.
  • Monitor urine output closely; oliguria significantly increases the risk of magnesium toxicity.
  • Assess deep tendon reflexes (DTRs) frequently; loss of DTRs is an early sign of hypermagnesemia.
  • Respiratory rate should be monitored hourly; respiratory depression is a serious complication of hypermagnesemia.
  • Magnesium sulfate is contraindicated in patients with myocardial damage or heart block.
  • For pre-eclampsia/eclampsia, continue magnesium sulfate for at least 24 hours postpartum or until the patient is stable and seizure-free.
🔄

Alternative Therapies

  • For eclampsia/pre-eclampsia: Antihypertensives (e.g., labetalol, hydralazine) for blood pressure control; other anticonvulsants (e.g., phenytoin, benzodiazepines) are less preferred for eclampsia.
  • For hypomagnesemia: Oral magnesium supplements (for mild cases).
  • For asthma: Beta-agonists, corticosteroids, anticholinergics.
  • For Torsades de Pointes: Electrical cardioversion, isoproterenol, overdrive pacing.
💰

Cost & Coverage

Average Cost: $5 - $50 per 10ml vial (50%)
Generic Available: Yes
Insurance Coverage: Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health problems persist or worsen, it is essential to contact your doctor for further guidance. To ensure safe use, never share your medication with others, and do not take medication prescribed for someone else. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion. Dispose of unused or expired medications properly. Unless instructed to do so by a healthcare professional, do not flush medications down the toilet or pour them down the drain. If you are unsure about the proper disposal method, consult your pharmacist for guidance. Many communities have drug take-back programs, which your pharmacist can help you locate. Some medications may come with an additional patient information leaflet; check with your pharmacist to see if this applies to your prescription. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken to ensure prompt and effective treatment.